Evidence map›Paper›PMID 41929502›Full record

ArticleFrontiers in immunology2026

Integrated network pharmacology and

Jinhai Shao, Qiongdan Zhang, Huanlong Du, Dongzhi Wang, Jiwei Mao, Guifang Gu

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jinhai Shao *Department of Critical Care Medicine, Shangyu People's Hospital of Shaoxing, Shaoxing University, Shaoxing, China.
Qiongdan Zhang *Department of The First Clinical Medical School, Hainan Medical University, Haikou, China.
Huanlong DuDepartment of Critical Care Medicine, Shangyu People's Hospital of Shaoxing, Shaoxing University, Shaoxing, China.
Dongzhi WangDepartment of Critical Care Medicine, Shangyu People's Hospital of Shaoxing, Shaoxing University, Shaoxing, China.
Jiwei MaoDepartment of Radiation Oncology, Shaoxing People's Hospital, Shaoxing, China.
Guifang GuDepartment of Respiratory Medicine, Shangyu People's Hospital of Shaoxing, Shaoxing University, Shaoxing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Acute lung injury (ALI), characterized by diffuse alveolar damage and inflammation, can trigger secondary enteritis through systemic interactions, aligning with the established lung-gut axis concept-a bidirectional communication system underpinned by shared mechanisms including inflammation, oxidative stress, and barrier dysfunction; however, the molecular links remain unclear, and vitamin E's role in this axis lacks systematic investigation. Methods: By integrating GeneCards database screening, protein-protein interaction (PPI) network, and pathway analyses. Results: we identified 34 "ALI-Enteritis ∩ Vitamin E" related core genes. In an LPS-induced ALI mouse model, vitamin E alleviated lung pathology while repairing intestinal mucosal barrier through modulating M1/M2 macrophage polarization and suppressing excessive neutrophil recruitment. This study first systematically delineates molecular commonalities between ALI and enteritis, identifies 34 shared therapeutic targets, and demonstrates vitamin E's coordinated multi-organ protection via targeting these pathways. Discussion: offering novel insights into the "lung-intestine axis" and a scientific basis for its nutritional-immunomodulatory intervention in multi-organ injury.

Indexed as

Acute Lung InjuryEnteritisVitamin EAnimalsDisease Models, AnimalHumansLipopolysaccharidesLungMiceProtein Interaction MapsLipopolysaccharidesVitamin Eacute lung injurylung–gut axisnetwork pharmacologysecondary enteritisvitamin E

Identifiers

PMID41929502
PMCPMC13038555

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.